A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2
抗 SARS-CoV-2 皮内可控自复制核糖核酸疫苗 EXG-5003 的 I/II 期临床试验
期刊:Vaccines
影响因子:
doi:10.3390/vaccines11121767
Takenao Koseki, Mayumi Teramachi, Minako Koga, Minoru S H Ko, Tomokazu Amano, Hong Yu, Misa Amano, Erica Leyder, Maria Badiola, Priyanka Ray, Jiyoung Kim, Akihiro C Ko, Achouak Achour, Nan-Ping Weng, Takumi Imai, Hisako Yoshida, Satsuki Taniuchi, Ayumi Shintani, Hidetsugu Fujigaki, Masashi Kondo, Yo